当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析 - 现金流量表

前沿生物-U

(688221)

  

流通市值:70.57亿  总市值:70.57亿
流通股本:3.75亿   总股本:3.75亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金82,793,398.9151,351,668.5525,672,208.61173,854,060.54
  收到其他与经营活动有关的现金6,197,729.925,224,719.411,939,895.817,694,401.99
  经营活动现金流入小计88,991,128.8356,576,387.9627,612,104.41191,548,462.53
  购买商品、接受劳务支付的现金25,612,230.2714,801,676.937,188,686.6359,529,551.19
  支付给职工以及为职工支付的现金80,771,678.157,156,170.5333,366,648.78125,449,789.59
  支付的各项税费2,381,331.421,575,699.89789,232.134,210,447.28
  支付其他与经营活动有关的现金132,015,477.6481,270,682.334,936,864.95174,874,986.52
  经营活动现金流出小计240,780,717.43154,804,229.6576,281,432.49364,064,774.58
  经营活动产生的现金流量净额-151,789,588.6-98,227,841.69-48,669,328.08-172,516,312.05
二、投资活动产生的现金流量:
  取得投资收益收到的现金10,209,145.797,184,561.173,548,498.3415,618,377.6
  处置固定资产、无形资产和其他长期资产收回的现金净额28,00028,00028,00025,690
  处置子公司及其他营业单位收到的现金净额15,128,712.3315,128,712.33-48,663,920.15
  收到的其他与投资活动有关的现金2,453,828,1001,534,298,100852,460,0003,376,840,000
  投资活动现金流入小计2,479,193,958.121,556,639,373.5856,036,498.343,441,147,987.75
  购建固定资产、无形资产和其他长期资产支付的现金26,075,665.3123,669,991.9617,392,130.9118,601,345.54
  支付其他与投资活动有关的现金2,397,670,0001,442,550,000776,260,0003,613,328,100
  投资活动现金流出小计2,423,745,665.311,466,219,991.96793,652,130.913,631,929,445.54
  投资活动产生的现金流量净额55,448,292.8190,419,381.5462,384,367.43-190,781,457.79
三、筹资活动产生的现金流量:
  取得借款收到的现金289,559,879.25216,774,00039,000,000393,926,406.17
  筹资活动现金流入小计289,559,879.25216,774,00039,000,000393,926,406.17
  偿还债务支付的现金323,472,535.62289,433,314.3780,819,598.05285,140,067.94
  分配股利、利润或偿付利息支付的现金6,303,490.884,520,884.012,420,320.5114,909,560.81
  支付其他与筹资活动有关的现金15,000,000-179,5218,264,079
  筹资活动现金流出小计344,776,026.5293,954,198.3883,419,439.56308,313,707.75
  筹资活动产生的现金流量净额-55,216,147.25-77,180,198.38-44,419,439.5685,612,698.42
四、汇率变动对现金及现金等价物的影响-26,046.19-15,167.51-4,608.064,532.33
五、现金及现金等价物净增加额-151,583,489.23-85,003,826.04-30,709,008.27-277,680,539.09
  加:期初现金及现金等价物余额248,719,957.82248,719,957.82248,719,957.82526,400,496.91
  期末现金及现金等价物余额97,136,468.59163,716,131.78218,010,949.55248,719,957.82
补充资料:
  净利润--97,352,610.68--201,382,610.39
  资产减值准备-89,923.13-46,727,551.35
  固定资产和投资性房地产折旧-9,121,391.86-15,479,494.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,121,391.86-15,479,494.94
  无形资产摊销-10,998,831.51-24,296,348.74
  长期待摊费用摊销-299,227.67-479,051.25
  处置固定资产、无形资产和其他长期资产的损失--15,353.93--18,798.64
  固定资产报废损失---52,830.32
  公允价值变动损失-297,011.44--83,505.51
  财务费用-3,796,838.12-11,335,662.14
  投资损失-1,861,944.89--84,091,885.06
  存货的减少--13,804,530.31-9,488,617.28
  经营性应收项目的减少--1,825,792.17-38,598,114.15
  经营性应付项目的增加--13,385,260.26--35,107,090.08
  现金的期末余额-163,716,131.78-248,719,957.82
  减:现金的期初余额-248,719,957.82-526,400,496.91
  现金及现金等价物的净增加额--85,003,826.04--277,680,539.09
公告日期2025-10-312025-08-302025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑